Zusammenfassung
Die Hypertonie gilt seit vielen Jahren als Gefäßerkrankung, die sich haupsächlich auf das Kaliber kleiner Arterien auswirkt, woraus eine Zunahme des Gefäß Widerstands und sekundäre schädliche Folgen für das Herz resultieren. Die Tatsache, daß die Hypertonie alle Komponenten des kardiovaskulären Systems beeinflußt, wozu auch eine Abnahme der arteriellen und venösen Compliance gehört, blieb zum Teil unbeachtet [1]. Veränderungen der Compliance, v. a. im Bereich des arteriellen Systems, müssen jedoch für ein besseres Verständnis der kardiovaskulären Morbidität und Mortalität bei Patienten, die wegen einer Hypertonie behandelt werden, unbedingt in Betracht gezogen werden. Tatsächlich stehen kardiovaskuläre Ereignisse bei antihypertensiv behandelten Patienten hauptsächlich mit einer Durchblutungsstörung größerer Arterien in Zusammenhang [2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Safar ME, London GM (1987) Arterial and venous compliance in sustained essential hypertension. Hypertension 10: 133–139
Kannel WB, Stokes III (1985) Hypertension as a cardiovascular risk factor. In: Blupitt CJ (ed) Epidemiology of hypertension. Elsevier, Amsterdam (Handbook of hypertension, vol 6, pp 15–34 )
O’Rourke MF (1982) Arterial function in health and disease. Churchill Livingstone, Edinburgh London Melbourne New York, pp 3–32, 53–93, 170–224
Westerhof N, Huisman RM (1987) Arterial haemodynamics of hypertension. Clin Sei 72: 391–398
Safar ME (1985) Focus on the large arteries in hypertension. J Cardiovasc Pharmacol [Suppl 2] 7: S1 - S4
Milnor WR (1982) Hemodynamics. Williams & Wilkins, Baltimore London, pp 11–48, 56–96, 192–239
Safar ME & Simon (1986) Hemodynamics in systolic hypertension. In: Zanchetti A, Tarazi RC (eds) Pathophisiology of hypertension, cardiovascular aspect. Elsevier, Amsterdam (Handbook of hypertension, vol 7, pp 225–241 )
Safar M, Peronneau J, Levenson J, Simon A (1981) Pulsed Doppler: diameter, velocity and flow of brachial artery in sustained essential hypertension. Circulation 63 /2: 393–400
Laurent S, Lacolley P, London G, Safar M (1988) Hemodynamics of the carotid artery after vasodilatation in essential hypertension. Hypertension 11: 134–1490
Isnard RN, Pannier BM, Laurent S, London GM, Diebold B, Safar ME (1989) Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. J Am Coli Cardiol 13: 399–405
Safar ME, Laurent S, Pannier BM, London GM (1987) Structural and functional modifications of peripheral large arteries in hypertensive patients. J Clin Hypertens 3: 360–367
Levy BI, Michel JB, Salzmann JL, Azizi M, Poitevin P, Safar M, Camilleri JP (1988) Effects of chronic inhibition of Converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res 63: 227–229
Cox RH (1979) Comparison of arterial wall mechanics in normotensive and spontaneously hypertensive rats. Am J Physiol 237 /2: H159 - H167
Safar ME, Simon A, Levenson JA, Cazor JL (1983) Hemodynamic effects of diltiazem in hypertension. Circ Res [Suppl 1] 52: 169–173
Safar ME, Laurent S, Bouthier JA, London GM (1986) Comparative effects of Captopril and isorbide dinitrate on the arterial wall of hypertensive human brachial arteries. J Cardiovasc Pharmacol 8: 1257–1261
Safar ME, Toto–Moukouo JJ, Bouthier JA, Asmar RE, Levenson JA, Simon AC, London GM (1987) Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation [Suppl 1] 75: 1–156–1–165
Safar ME (1988) Therapeutic trials and large arteries in hypertension. Am Heart J 115: 702–710
Safar ME, London GM, Asmar RG, Hugues CJ, Laurent S (1986) An indirect approach for the study of the elastic modulus of the brachial artery in patients with essential hypertension. Cardiovasc Res 20: 563–567
Levy BI, Michel JB, Salumann JL, Azizi M, Poitevin P, Camilleri JP, Safar ME (1988) Arterial effects of angiotensin Converting enzyme inhibition in renovascular and spontaneously hypertensive rats. J Hypertens [Suppl 3] 6: S23 - S25
Asmar RG, Pannier B, Santoni JP, Laurent S, London GM, Levy BI, Safar ME (1988) Reversion of cardiac hypertrophy and reduced arterial compliance after Converting enzyme inhibition in essential hypertension. Circulation 789: 941–950
Asmar RG, Journo HJ, Lacolley PJ, Santoni JP, Billaud E, Levy BI, Safar ME (1988) Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension. J Hypertens [Suppl 3] 6: S23 - S25
Kannel WB, Gordon T, Schwartz MJ (1971) Systolic versus diastolic blood pressure and risk of coronary heart disease: The Framingham Study. Am J Cardiol 27: 335–346
Darne B, Girerd X, Safar M, Cambien F, Guize L (1989) Pulsatile versus steady component of blood pressure: A cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 13: 392–400
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Safar, M.E., Cuche, J.L., Pannier, B.M. (1991). Abnahme der arteriellen Compliance: Beurteilung und Behandlung. In: Schmieder, R.E., Müller, HM., Messerli, F.H. (eds) Endorganschädigungen der arteriellen Hypertonie — Konsequenzen für Diagnostik und Therapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76361-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-76361-8_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53581-2
Online ISBN: 978-3-642-76361-8
eBook Packages: Springer Book Archive